EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

Serena Ricciardi, Silverio Tomao, Filippo de Marinis

Lung Cancer: Targets and Therapy · 2010

DOI: 10.2147/lctt.s10167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2010. Verfasst von Serena Ricciardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic-Oncology Unit 1st, Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

NSCLCerlotinibtargeted therapy

Autor:innen und Institutionen

  • Thoracic-Oncology Unit 1st, Lung Diseases Department, San Camillo-Forlanini High Specialization Hospitals, Rome, Italy.
  • Sperimental Medicine Department, La Sapienza University, Rome, Italy.

Zitieren

APA

Ricciardi, S., Tomao, S., & de Marinis, F. (2010). Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer. Lung Cancer: Targets and Therapy. https://doi.org/10.2147/lctt.s10167

Vancouver

Ricciardi S, Tomao S, de Marinis F. Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer. Lung Cancer: Targets and Therapy. 2010. doi:10.2147/lctt.s10167

BibTeX
@article{Ricciardi2010,
  author = {Ricciardi, Serena and Tomao, Silverio and de Marinis, Filippo},
  title = {Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer},
  journal = {Lung Cancer: Targets and Therapy},
  year = {2010},
  doi = {10.2147/lctt.s10167}
}
Kostenlos starten →